Completed PHASE1 INTERVENTIONAL 2-arm
NCT07292025
Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity
A Randomized, Double-blind, Active-controlled, Multicenter, Phase 1 Trial to Investigate the Safety and Efficacy of JTM201 in Subjects With Post-stroke Upper Limb Spasticity
Sponsor: Jetema Co., Ltd.
Conditions
Upper Limb Spasticity Post-Stroke
Interventions
BOTOX 100U in normal saline JTM201 in normal saline
Updated 1 time since 2026 Last updated: Dec 5, 2025 Started: Jun 29, 2023 Primary completion: Apr 22, 2024 Completion: Sep 4, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Upper Limb Spasticity Post-Stroke and is currently completed. Jetema Co., Ltd. leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jetema Co., Ltd.
Data source: Jetema Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .